Results 231 to 240 of about 3,358,332 (268)
Some of the next articles are maybe not open access.
Cyclophosphamide and Etoposide for Non-Small Cell and Small Cell Lung Cancer
Drugs, 1999Oral chemotherapeutic regimens with limited toxicity are desirable in that quality of life can be maintained and clinic/hospital visits minimised during therapy. We have investigated the use of extended courses of oral cyclophosphamide and oral etoposide for the treatment of non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). A 14-day
openaire +2 more sources
Acta Neuropathologica, 1982
Fourteen juvenile patients with small cell gliomas were studied at two institutes. These tumors are believed to form a distinct entity. They arise mostly in the diencephalon or the brain stem and are composed of a poorly differentiated small cell component having a pronounced tendency to differentiate into a glioma.
R L, Friede, R C, Janzer, U, Roessmann
openaire +2 more sources
Fourteen juvenile patients with small cell gliomas were studied at two institutes. These tumors are believed to form a distinct entity. They arise mostly in the diencephalon or the brain stem and are composed of a poorly differentiated small cell component having a pronounced tendency to differentiate into a glioma.
R L, Friede, R C, Janzer, U, Roessmann
openaire +2 more sources
Current Problems in Cancer, 1989
Lung cancer is the most common cause of cancer death in the United States, with approximately 135,000 men and women dying each year. While much has been learned about the etiologic risk factors, less progress has been made in therapy. Five-year survival rates remain at less than 10%.
G E, Goodman, R B, Livingston
openaire +3 more sources
Lung cancer is the most common cause of cancer death in the United States, with approximately 135,000 men and women dying each year. While much has been learned about the etiologic risk factors, less progress has been made in therapy. Five-year survival rates remain at less than 10%.
G E, Goodman, R B, Livingston
openaire +3 more sources
Small cell bronchogenic carcinoma
Current Problems in Cancer, 1986We have attempted to highlight the most important aspects of SCBC in this review. The significant strides made in a variety of areas have been associated with increased response rates and survival as well as with a prolonged disease-free interval in a fraction of patients.
M, Perloff, J Y, Killen, R E, Wittes
openaire +2 more sources
Therapy for small cell and non-small cell lung cancer
Current Opinion in Oncology, 1990C P, Belani, J, Aisner
openaire +2 more sources
Small cell carcinoma of the esophagus.
Neoplasma, 1999Small cell carcinoma of the esophagus (SCEC) is a rare tumor with its particular biologic features, distinct from squamous and glandular carcinoma of esophagus. Although initial symptoms can be similar (with metastatic dissemination and paraneoplastic syndromes at presentation more frequent in SCEC), differences in age and sex distribution, tumor ...
B. Jereczek-Fossa +5 more
openaire +2 more sources
Small-Cell Carcinoma of the Prostate
Journal of Clinical Oncology, 2008Christopher J, Anker +4 more
openaire +2 more sources